Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 9;22(22):12122.
doi: 10.3390/ijms222212122.

The Importance of 6-Aminohexanoic Acid as a Hydrophobic, Flexible Structural Element

Affiliations
Review

The Importance of 6-Aminohexanoic Acid as a Hydrophobic, Flexible Structural Element

Agnieszka Markowska et al. Int J Mol Sci. .

Abstract

6-aminohexanoic acid is an ω-amino acid with a hydrophobic, flexible structure. Although the ω-amino acid in question is mainly used clinically as an antifibrinolytic drug, other applications are also interesting and important. This synthetic lysine derivative, without an α-amino group, plays a significant role in chemical synthesis of modified peptides and in the polyamide synthetic fibers (nylon) industry. It is also often used as a linker in various biologically active structures. This review concentrates on the role of 6-aminohexanoic acid in the structure of various molecules.

Keywords: 6-aminohexanoic acid; antifibrynolytics; linker.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structure of 6-aminohexanoic acid.
Figure 2
Figure 2
Scheme of the plasminogen–plasmin system. Inactive plasminogen is converted into plasmin as a result of an action of plasminogen activators (natural: urokinase plasminogen activator or tissue plasminogen activator, or synthetic: streptokinase). Plasmin then enables the degradation of fibrinogen (a plasma protein) as well as the degradation of the fibrin clot into fibrin cleavage products. The unbound circulating fibrinogen is converted into fibrin clot by thrombin. The formation of plasmin from plasminogen can be inhibited by antifibrinolytic drugs (Ahx). The interaction of Ahx with plasminogen or plasmin, as well as plasmin with fibrin or fibrinogen, is mediated by lysine binding sites, not enzymatic active sites of plasmin. Green arrows = activation, red arrows = inhibition.
Figure 3
Figure 3
Ahx as fragment of molecules with biological activity.
Figure 4
Figure 4
Examples of structures using Ahx as linker in receptor affinity peptide structures.

References

    1. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) Nomenclature and Symbolism for Amino Acids and Peptides. Corrections to Recommendations 1983. Eur. J. Biochem. 1993;213:2. doi: 10.1111/j.1432-1033.1993.tb17727.x_2. - DOI - PubMed
    1. Al-Horani R.A., Desai U.R. Recent Advances on Plasmin Inhibitors for the Treatment of Fibrinolysis-Related Disorders. Med. Res. Rev. 2014;34:1168–1216. doi: 10.1002/med.21315. - DOI - PMC - PubMed
    1. Bellussi G., Perego C. Industrial Catalytic Aspects of the Synthesis of Monomers for Nylon Production. Cattech. 2020;4:4–16. doi: 10.1023/A:1011905009608. - DOI
    1. Meyers C.Y., Miller L.E. ε-Aminocaproic Acid. [(accessed on 25 October 2021)];Org. Synth. 1952 32:13. Erratum in 1963, 4, 39. Available online: http://www.orgsyn.org/Content/pdfs/procedures/CV4P0039.pdf.
    1. Sattler J.H., Fuchs M., Mutti F.G., Grischek B., Engel P., Pfeffer J., Woodley J., Kroutil W. Introducing an In Situ Capping Strategy in Systems Biocatalysis to Access 6-Aminohexanoic acid. Angew. Chem. Int. Ed. 2014;53:14153–14157. doi: 10.1002/anie.201409227. - DOI - PubMed

MeSH terms

LinkOut - more resources